No. |
Product Name |
CAS No. |
Spec |
Price |
|
| 1719500 |
Withanolide A (15 mg) |
32911-62-9 |
|
|
| 1719532 |
Withanoside IV (15 mg) |
362472-81-9 |
|
|
| 1720000 |
Xanthanoic Acid (100 mg) |
82-07-5 |
|
|
| 1720203 |
Xanthone (100 mg) |
90-47-1 |
|
|
| 1720600 |
Xylitol (1 g) |
87-99-0 |
|
|
| 1721002 |
Xylometazoline Hydrochloride (250 mg) |
1218-35-5 |
|
|
| 1722005 |
Xylose (1 g) |
58-86-6 |
|
|
| 1724000 |
Yohimbine Hydrochloride (200 mg) |
65-19-0 |
|
|
| 1724066 |
Zanamivir Resolution Mixture (0.25 mg) (Mixture of zanamivir and talo-zanamivir) |
N/A |
|
|
| 1724077 |
Zanamivir Related Compounds Mixture (2.5 mg) |
N/A |
|
|
| 1724088 |
Zanamivir (200 mg) |
139110-80-8 |
|
|
| 1724306 |
Zalcitabine (200 mg) |
7481-89-2 |
|
|
| 1724317 |
Zalcitabine Related Compound A (50 mg) (2’,3’-Didehydro-2’,3’-dideoxycytidine) |
7481-88-1 |
|
|
| 1724361 |
Zaleplon Related Compound A CIV (15 mg) ((E)-N-(3-[3-(dimethylamino)acryloyl]phenyl)-N-ethylacetamide) |
96605-66-2 |
|
|
| 1724372 |
Zaleplon Related Compound B CIV (15 mg) (N-[3-(3-Cyanopyrazolo[1,5-alpha]pyrimidin-5-yl)phenyl]-N-ethylacetamide) |
N/A |
|
|
| 1724408 |
Ziprasidone Hydrochloride (200 mg) |
138982-67-9 |
|
|
| 1724419 |
Ziprasidone Related Compound A (10 mg) (3-(Piperazin-1-yl)benzo[d]isothiazole monohydrochloride) |
87691-88-1 |
|
|
| 1724420 |
Ziprasidone Related Compound B (10 mg) (5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindoline-2,3-dione) |
N/A |
|
|
| 1724441 |
Ziprasidone Related Compound C (10 mg) (5,5’-Bis(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6,6’-dichloro-3-hydroxy-3,3’-biindoline-2,2’-dione) |
1303996-68-0 |
|
|
| 1724452 |
Ziprasidone Related Compound D (10 mg) (3-(Benzo[d]isothiazol-3-yl)-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one) |
N/A |
|
|
